News | July 03, 2012

U.K. Patient First to Benefit from Treatment Combining Elekta's New Beam-Shaping Collimation

July 3, 2012 — A 51-year-old male became the first person to benefit from a radiation therapy technique that provides exceptional precision and high-speed delivery. Clinicians at St. James's University Hospital used Elekta's Agility multileaf collimator (MLC) and Elekta volumetric modulated arc therapy (VMAT) to treat the patient's tongue cancer. The combination of the two innovations reduced the time it takes to deliver the radiation beams from five minutes down to just two minutes.

Recently released for sale across Europe, and with 510(k) clearance in the United States, Agility is Elekta's revolutionary new MLC. The device comprises many individual tungsten leaves used to shape beams of radiation as therapeutic doses are delivered from different angles around the patient. Agility's 160, five-millimeter wide leaves are capable of traveling at twice the speed of those in a conventional MLC, and provide a much-improved ability to conform to the shape of tumors.

Elekta VMAT is an advanced radiation therapy technique that delivers treatment in one or more continuous high-speed arcs around the patient, enabling the radiation dose to precisely conform to a tumor by modulating the radiation beam's intensity during gantry rotation. Clinicians can use Elekta VMAT with complete or partial arc(s) to reduce treatment times substantially.

Elekta's Monaco treatment planning system also contributed to the patient's treatment by enabling much lower parotid (salivary gland) and larynx doses than traditional plans the Leeds team had been producing.

For more information: www.elekta.com 

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more